ArticleEuropean journal of cancer (Oxford, England : 1990)2013

A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.

El Mustapha Bahassi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.